Contact

In the Media

  • Zero Candida

Zero Candida begins trading on OTCQB, advances AI-driven women’s health solutions
  • Zero Candida

Zero Candida secures patent in South Africa for revolutionary AI-powered fungal treatment device
  • Zero Candida

Zero Candida celebrates TSX Venture listing and debuts treatment for recurrent yeast infections
  • Zero Candida

Zero Candida, an Israeli FemTech medical device start-up applying to list on TSX Venture Exchange

Vulvovaginal candidiasis market poised for $2B growth by 2030

Zero Candida starts trading on the OTCQB Venture Market

Zero Candida eyes FDA submission for AI-powered yeast infection treatment device

Zero Candida is revolutionizing yeast infection care with AI-driven blue-light therapy

AI Market Forecast: Top Trends for AI in 2025

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

Zero Candida Technologies Inc. (ZCT) Opens the Market

Galil-based Israeli start-up Zero Candida reports 99.99% success rate in breakthrough Candida treatment...

Contact Us.

Contact